122 related articles for article (PubMed ID: 16882499)
1. Papillary thyroid cancer.
Sosa JA; Udelsman R
Surg Oncol Clin N Am; 2006 Jul; 15(3):585-601. PubMed ID: 16882499
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis, treatment, prognostic factors and long-term outcome in papillary thyroid carcinoma.
Pelizzo MR; Merante Boschin I; Toniato A; Pagetta C; Casal Ide E; Mian C; Rubello D
Minerva Endocrinol; 2008 Dec; 33(4):359-79. PubMed ID: 18923371
[TBL] [Abstract][Full Text] [Related]
3. (18)F-FDG PET discovered an elusive cervical inflammatory pseudotumor associated with a papillary thyroid cancer.
Modesto J; Gardeazabal I; Santos AM; Galofré JC
Endocrinol Nutr; 2014; 61(6):338-40. PubMed ID: 24721020
[No Abstract] [Full Text] [Related]
4. Encapsulation status of papillary thyroid microcarcinomas is associated with the risk of lymph node metastases and tumor multifocality.
Cupisti K; Lehwald N; Anlauf M; Riemer J; Werner TA; Krieg A; Witte J; Chanab A; Baldus SE; Krausch M; Raffel A; Herdter C; Schott M; Knoefel WT
Horm Metab Res; 2014 Feb; 46(2):138-44. PubMed ID: 24356791
[TBL] [Abstract][Full Text] [Related]
5. [BRAF V600E mutation in papillary thyroid carcinoma: prevalence and detection in fine needle aspiration specimens].
Dujardin F; Pagès JC; Collin C; de Calan L; Lecomte P; Guyétant S
Ann Pathol; 2010 Aug; 30(4):252-62. PubMed ID: 20837233
[TBL] [Abstract][Full Text] [Related]
6. Papillary thyroid carcinoma tall cell variant.
Ghossein R; Livolsi VA
Thyroid; 2008 Nov; 18(11):1179-81. PubMed ID: 18925842
[TBL] [Abstract][Full Text] [Related]
7. Treatment of persistent or recurrent papillary carcinoma of the thyroid--the good, the bad, and the unknown.
Udelsman R
J Clin Endocrinol Metab; 2010 May; 95(5):2061-3. PubMed ID: 20444934
[No Abstract] [Full Text] [Related]
8. [BRAF(T1799A) mutation in the primary tumor as a marker of risk, recurrence, or persistence of papillary thyroid carcinoma].
Cañadas Garre M; López de la Torre Casares M; Becerra Massare P; López Nevot MÁ; Villar Del Moral J; Muñoz Pérez N; Vílchez Joya R; Montes Ramírez R; Llamas Elvira JM
Endocrinol Nutr; 2011 Apr; 58(4):175-84. PubMed ID: 21441079
[TBL] [Abstract][Full Text] [Related]
9. Use of molecular biomarkers in FNA specimens to personalize treatment for thyroid surgery.
Mehta V; Nikiforov YE; Ferris RL
Head Neck; 2013 Oct; 35(10):1499-506. PubMed ID: 22972563
[TBL] [Abstract][Full Text] [Related]
10. TERT promoter mutations in thyroid cancer: a report from a Middle Eastern population.
Qasem E; Murugan AK; Al-Hindi H; Xing M; Almohanna M; Alswailem M; Alzahrani AS
Endocr Relat Cancer; 2015 Dec; 22(6):901-8. PubMed ID: 26354077
[TBL] [Abstract][Full Text] [Related]
11. Treatment for microcarcinoma of the thyroid--clinical experience.
Küçük NO; Tari P; Tokmak E; Aras G
Clin Nucl Med; 2007 Apr; 32(4):279-81. PubMed ID: 17413573
[TBL] [Abstract][Full Text] [Related]
12. Cribriform-morular variant of papillary thyroid carcinoma: characteristic histologic feature of adenomatous polyposis. A case report.
Gronnier C; Donatini G; Leteurtre E; Do Cao C; Carnaille B
Ann Endocrinol (Paris); 2012 Jun; 73(3):213-5. PubMed ID: 22387099
[TBL] [Abstract][Full Text] [Related]
13. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
[TBL] [Abstract][Full Text] [Related]
14. Management of the lateral neck in well differentiated thyroid cancer.
Cracchiolo JR; Wong RJ
Eur J Surg Oncol; 2018 Mar; 44(3):332-337. PubMed ID: 28687430
[TBL] [Abstract][Full Text] [Related]
15. Higher administered activities of radioactive iodine are associated with less structural persistent response in older, but not younger, papillary thyroid cancer patients with lateral neck lymph node metastases.
Sabra MM; Grewal RK; Ghossein RA; Tuttle RM
Thyroid; 2014 Jul; 24(7):1088-95. PubMed ID: 24559250
[TBL] [Abstract][Full Text] [Related]
16. BRAF V600E mutation analysis increases diagnostic accuracy for papillary thyroid carcinoma in fine-needle aspiration biopsies.
Zatelli MC; Trasforini G; Leoni S; Frigato G; Buratto M; Tagliati F; Rossi R; Cavazzini L; Roti E; degli Uberti EC
Eur J Endocrinol; 2009 Sep; 161(3):467-73. PubMed ID: 19574281
[TBL] [Abstract][Full Text] [Related]
17. Applying Criteria of Active Surveillance to Low-Risk Papillary Thyroid Cancer Over a Decade: How Many Surgeries and Complications Can Be Avoided?
Griffin A; Brito JP; Bahl M; Hoang JK
Thyroid; 2017 Apr; 27(4):518-523. PubMed ID: 28125944
[TBL] [Abstract][Full Text] [Related]
18. Optimizing surgical treatment of papillary thyroid carcinoma associated with BRAF mutation.
Yip L; Nikiforova MN; Carty SE; Yim JH; Stang MT; Tublin MJ; Lebeau SO; Hodak SP; Ogilvie JB; Nikiforov YE
Surgery; 2009 Dec; 146(6):1215-23. PubMed ID: 19958951
[TBL] [Abstract][Full Text] [Related]
19. Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients.
Kazaure HS; Roman SA; Sosa JA
Ann Surg Oncol; 2012 Jun; 19(6):1874-80. PubMed ID: 22065195
[TBL] [Abstract][Full Text] [Related]
20. Management of microcarcinomas (papillary and medullary) of the thyroid.
Wu LS; Milan SA
Curr Opin Oncol; 2013 Jan; 25(1):27-32. PubMed ID: 23042124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]